5-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases

The invention relates to the use of a compound of formula (I) or a pharmaceutically acceptable salt, prodrug and/or solvate thereof, in the preparation of a medicament for the treatment of an acute or chronic inflammatory disease, by inhibiting the production of at least one pro-inflammatory cytokin...

Full description

Saved in:
Bibliographic Details
Main Authors RUBIO ROYO VICTOR, ALVAREZ DE MON SOTO MELCHOR, DE LA HERA MARTINEZ ANTONIO, MUNOZ MUNOZ ANA
Format Patent
LanguageChinese
English
Published 01.06.2011
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention relates to the use of a compound of formula (I) or a pharmaceutically acceptable salt, prodrug and/or solvate thereof, in the preparation of a medicament for the treatment of an acute or chronic inflammatory disease, by inhibiting the production of at least one pro-inflammatory cytokine selected from TNF-alpha and IFN-gamma, or by inmunomodulating the IL-8 chemokine and/or the IL-10 regulatory cytokine. The invention also relates to novel compounds of formula (I') or a pharmaceutically acceptable salt, prodrug and/or solvate thereof, as well as a pharmaceutical composition comprising said compound.
Bibliography:Application Number: CN200980122682